The objective of this study was to examine the potential of vaginal an
d rectal mucosal routes for feline immunodeficiency virus (FIV) uptake
and infection, as a model of mucosal HIV infection, and to determine
the fate of virus at these mucosal sites following transmission of inf
ection. SPF cats were exposed to FIV isolates (PET, GL-8, T637), admin
istered as either cell-associated or cell-free inocula, via the rectum
or vagina. Establishment of infection was confirmed by isolation of i
nfectious FIV from peripheral blood mononuclear cells (PBMC), and by p
resence of FIV proviral DNA in PBMC, using a nested polymerase chain r
eaction. Fate of virus in tissue taken at necropsy from, cats infected
for 6-48 weeks was assessed by localizing FIV core and envelope prote
ins, p24 and gp41, using a biotin-streptavidin linked immunoperoxidase
(IP) technique. Cells susceptible to infection were identified by an
in situ hybridization technique for FIV viral DNA and RNA. Cell-free,
as well as cell-associated, virus was infectious across intact vaginal
and rectal mucosal surfaces. Transmission was most successful using c
ell-associated inocula, and via the rectal route. Cells infected with
FIV were detected by IP staining in the colon of 6/9 rectally challeng
ed cats and 1/5 vaginally challenged cats. Virus was predominantly loc
alized within the epithelium at the base of the colonic crypts associa
ted with lymphoid aggregates (follicle associated epithelium; FAE), an
d within the lymphoid follicle itself. Occasional infected cells were
also noted within the lamina propria. The distribution of FIV DNA posi
tive cells in the colon was similar to that for FIV antigen whilst FIV
RNA positive cells were found more extensively, including within the
lamina propria and lymphoid follicle. FIV infected cells were not dete
cted within the vagina, or colonic and ileac lymph nodes. Similar patt
erns of infected cells were seen in all of the positive cats, indicati
ng that colonic tissues remain persistently actively infected with FIV
. We conclude that the FIV/cat model of rectal and vaginal mucosal inf
ection should prove useful for characterizing the mechanism by which H
IV infects mucosal surfaces and as challenge system for the design of
vaccines effective at preventing HIV infection via rectal and vaginal
routes.